Form 8-K - Current report:
SEC Accession No. 0001193125-25-139137
Filing Date
2025-06-11
Accepted
2025-06-11 16:05:24
Documents
14
Period of Report
2025-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d55409d8k.htm   iXBRL 8-K 138139
2 EX-3.1 d55409dex31.htm EX-3.1 77324
  Complete submission text file 0001193125-25-139137.txt   398958

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20250611.xsd EX-101.SCH 3100
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20250611_def.xml EX-101.DEF 14267
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20250611_lab.xml EX-101.LAB 23642
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20250611_pre.xml EX-101.PRE 15165
16 EXTRACTED XBRL INSTANCE DOCUMENT d55409d8k_htm.xml XML 6298
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 251039944
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)